EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data

Ilya Lipkovich iD, David Svensson iD, Bohdana Ratitch iD, Alex Dmitrienko iD

Statistics in Medicine · 2024-09-30 · 43 (22) · 4388-4436

DOI: 10.1002/sim.10167 ↗

At a glance

Übersichtsarbeit in Statistics in Medicine, published online on 2024-07-25. Written by Ilya Lipkovich and 3 co-authors. Institution: Advanced Analytics and Access Capabilities, Eli Lilly and Company, Indianapolis, Indiana, USA. Major MEDLINE topics: Observational Studies as Topic, Randomized Controlled Trials as Topic. Cited 38 times so far (Crossref); 230 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

In this paper, we review recent advances in statistical methods for the evaluation of the heterogeneity of treatment effects (HTE), including subgroup identification and estimation of individualized treatment regimens, from randomized clinical trials and observational studies. We identify several types of approaches using the features introduced in Lipkovich et al ( Stat Med 2017;36: 136‐196) that distinguish the recommended principled methods from basic methods for HTE evaluation that typically rely on rules of thumb and general guidelines (the methods are often referred to as common practices). We discuss the advantages and disadvantages of various principled methods as well as common measures for evaluating their performance. We use simulated data and a case study based on a historical clinical trial to illustrate several new approaches to HTE evaluation.

Subjects

MeSH terms (MEDLINE)

Observational Studies as TopicRandomized Controlled Trials as TopicHumansTreatment OutcomeModels, StatisticalData Interpretation, StatisticalComputer SimulationTreatment Effect Heterogeneity

Author keywords

individualized treatment regimenpersonalized medicinesubgroup identification

Authors and institutions

  • Advanced Analytics and Access Capabilities, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Statistical Innovation, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Clinical Statistics and Analytics, Research & Development, Pharmaceuticals, Bayer Inc., Mississauga, Ontario, Canada.
  • Department of Biostatistics, Mediana, San Juan, Puerto Rico, USA.

ORCID profiles: Ilya Lipkovich, David Svensson, Bohdana Ratitch, Alex Dmitrienko

Cite

APA

Lipkovich, I., Svensson, D., Ratitch, B., & Dmitrienko, A. (2024). Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data. Statistics in Medicine, 43(22), 4388-4436. https://doi.org/10.1002/sim.10167

Vancouver

Lipkovich I, Svensson D, Ratitch B, Dmitrienko A. Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data. Statistics in Medicine. 2024;43(22):4388-4436. doi:10.1002/sim.10167

BibTeX
@article{Lipkovich2024,
  author = {Lipkovich, Ilya and Svensson, David and Ratitch, Bohdana and Dmitrienko, Alex},
  title = {Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data},
  journal = {Statistics in Medicine},
  year = {2024},
  volume = {43},
  number = {22},
  pages = {4388--4436},
  doi = {10.1002/sim.10167}
}
Start for free →